Type A (n = 61) | Type B (n = 104) | Pvalue | |
---|---|---|---|
Age, yrs | 68 ± 10 | 67 ± 12 | 0.521 |
Sex, male | 23 (37.7%) | 61 (58.7%) | 0.009 |
Diabetes | 4 (6.6%) | 7 (6.7%) | 0.966 |
Hypertension | 37 (60.7%) | 52 (50.0%) | 0.185 |
Dyslipidemia | 16 (36.4%) | 24 (31.6%) | 0.688 |
Current smoking | 20 (32.8%) | 30 (28.8%) | 0.595 |
Time from onset to admission (hrs) | 10.6 ± 16.2 | 7.9 ± 11.3 | 0.251 |
Initial symptoms | 0.372 | ||
Chest pain | 31 (50.8%) | 58 (55.8%) | 0.538 |
Abdominal pain | 11 (18.0%) | 21 (20.2%) | 0.735 |
Back pain | 10 (16.4%) | 19 (18.3%) | 0.760 |
Loss of consciousness | 2 (3.3%) | 3 (2.9%) | 1.000 |
Dyspnea | 4 (6.6%) | 1 (1.0%) | 0.159 |
Others | 3 (4.9%) | 2 (1.2%) | 0.360 |
Hemodynamic findings | |||
Systolic BP, mmHg | 138 ± 36 | 150 ± 36 | 0.042 |
Diastolic BP, mmHg | 84 ± 21 | 86 ± 19 | 0.522 |
Heart rate, BPM | 77 ± 18 | 77 ± 23 | 0.997 |
Laboratory findings | |||
Total cholesterol (mg/dL) | 185 ± 53 | 180 ± 46 | 0.550 |
C-reactive protein (mg/dL) | 3.2 ± 4.3 | 4.7 ± 8.3 | 0.236 |
Creatinine (mg/dL) | 1.20 ± 1.50 | 0.97 ± 0.34 | 0.279 |